Table 1 Baseline patient variables
Study | Year | Cohort size | Age (years) | Male % | HTN % | BMI (kg/m2) | LA diameter (cm) | PAF% | Persistent AF % | Mean Duration (months) | LVEF (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
Bisleri et al [16] | 2012 | 45 | 62.3 ± 9.8 | 33 (73%) | 34 (76%) |  | 5.1 ± 0.97 | 0 | 45 (100%) | 83.8 ± 69.1 | 56.3 ± 7 |
Bulava et al [17] | 2017 | 70 | 62.4 ± 7.9 | 49 (70%) | 55 (79%) | 30.8 ± 4.6 | 150 ± 34 (ml) | 0 | 70 (100%) | 41.8 ± 35 | 64 ± 8 |
De Asmundis et al [18] | 2019 | 51 | 65.7 ± 8 | 34 (67%) | 35 (69%) | 28.6 ± 4.9 | 76 ± 20 (ml) | 0 | 51 (100%) | 68.3 ± 62.4 | 56.8 ± 9.8 |
Dunnington et al [19] | 2021 | 451 | 67.1 ± 8.4 | 361 (80%) | NR | 30.5 ± 6 | 4.8 ± 0.8 | 10 (2%) | 441 (98%) | 70.8 ± 73.2 | 51.4 ± 10.5 |
Edgerton et al [20] | 2016 | 24 | 63.8 ± 8.9 | 22 (92%) | 15 (62.5%) | 30.8 ± 5 | 5.15 ± 0.28 | 0 | 24 (100%) | 81.6 ± 42 | 52.6 ± 8.6 |
Gersak et al [21] | 2016 | 76 | 56.6 ± 10.1 | NR | NR | NR | 4.7 ± 0.5 | NR | NR | NR | 59.2 ± 12 |
Hwang et al [22] | 2018 | 72 | 53.6 ± 8.46 | 71 (99%) | 31 (43%) | 25.3 ± 2.6 | 47.9 ml ± 14 | 0 | 72 (100%) | NR | 59.1 ± 6.5 |
Jan et al [23] | 2018 | 50 | 58.8 ± 6.3 | 16 (67%) | 18 (75%) | 30.6 ± 5.9 | 32.4 ± 8.5 (ml) | 25 (100%) | 0 | 49.2 ± 42 | 65.6 ± 6.15 |
Kim et al [24] | 2021 | 81 | 55.4 ± 8.5 | 80 (99%) | 34 (42%) | NR | 4.54 ± 0.61 | 13 (16%) | 68 (84%) | NR | NR |
Maclean et al [25] | 2020 | 43 | 68.6 ± 7.7 | 32 (74%) | NR | NR | 4.7 ± 0.63 | 0 | 43 (100%) | 36 ± 30 | 50 ± 15 |
Maesen et al [26] | 2018 | 64 | 59 ± 9 | 36 (57%) | 44 (68.8%) | 26.5 ± 4.7 | 3.9 ± 1.4 | 30 (47%) | 34 (53%) | 59 (12–348) (median/IQR) | 55 ± 16 |
Magni et al [27] | 2021 | 49 | 57 ± 8.5 | 44 (90%) | 21 (43%) | 29 ± 3.5 | 43.7 ± 10.9 (ml) | 0 | 49 (100%) | 34.8 (19.1–65.5) (median/IQR) | 52.4 ± 7.5 |
Ma et al [28] | 2021 | 40 | 61.4 ± 9.4 | 30 (75%) | NR | 26.8 ± 2.5 | 4.6 ± 0.46 | 0 | 40 (100%) | 51.6 ± 31.2 | 60 ± 7.1 |
Muneretto et al [29] | 2012 | 36 | 62.3 ± 10 | 17 (47%) | 15 (42%) | NR | 5.0 ± 0.55 | 0 | 36 (100%) | 72.8 (7–240) (median/IQR) | 52.5 ± 3.3 |
Pojar et al [30] | 2019 | 65 | 58.2 ± 8.3 | 49 (75%) | 44 (68%) | 30.3 ± 4.6 | 4.5 ± 0.54 | 30 (46%) | 35 (54%) | 43 (18.5–79) (median/IQR) | 60.5 ± 7.2 |
Tan et al [31] | 2021 | 50 | 60 ± 8.2 | 38 (76%) | NR | 26.5 ± 3.5 | 4.6 ± 0.7 | 0 | 50 (100%) | 73.3 ± 62.1 | 62 ± 9.1 |